francesco danilo tiziano

Associate professor

Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Francesco Danilo Tiziano is an Associate Professor at Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia in Italy. His research areas include neurology and genetics, with recent publications focusing on conditions such as familial hemiplegic migraine, spinal muscular atrophy, and the impact of genetic factors on COVID-19 severity. He is actively involved in studies analyzing both novel genetic mutations and clinical outcomes associated with various neurological disorders.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2021

Collaborators (5)

Antonia Ratti

IRCCS Istituto Auxologico Italiano

ITALY

View details

Eugenio Mercuri

Professor of Pediatric Neurology

Università Cattolica del Sacro Cuore

ITALY

View details

Anna Maria AZZINI

Aggregate Professor

University of Verona

ITALY

View details

Anna Capasso

Agostino Gemelli University Polyclinic

ITALY

View details

Silvia Peverelli

IRCCS Istituto Auxologico Italiano

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

francesco danilo tiziano

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Ataxia-Telangiectasia Presenting as Tremor-Predominant Syndrome in an Adult Patient without Ataxia and Telangiectasias

Clinical characterization of a novel ATP1A2 p.Gly615Glu mutation in nine family members with familial hemiplegic migraine

Efficacy of galcanezumab in proline-rich transmembrane protein 2 (PRRT2)-associated familial hemiplegic migraine: A case series

Myostatin Levels in SMA Following Disease-Modifying Treatments: A Multi-Center Study

Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation

Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity

Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?

Exome sequencing of ATP1A3-negative cases of alternating hemiplegia of childhood reveals SCN2A as a novel causative gene

Prognostic factors for tube feeding in type I SMA patients treated with disease-modifying therapies: a cohort study

Prognostic value of electroanatomic-guided endomyocardial biopsy in patients with myocarditis, arrhythmogenic cardiomyopathy and non dilated left ventricular cardiomyopathy

Reply to: The need for evidence‐based treatment decisions in spinal muscular atrophy type 0

Collaborators (5)

Antonia Ratti

Eugenio Mercuri

Anna Maria AZZINI

Anna Capasso

Silvia Peverelli

Make your next move.